Recombinant Human ACE Protein，His

The study of ACE (angiotensin-converting enzyme) recombinant proteins has gained significant traction due to the pivotal role of ACE in the renin-angiotensin system, which regulates blood pressure and fluid balance. Discovered in the 1970s, ACE converts angiotensin I into the active vasoconstrictor angiotensin II, thus influencing cardiovascular function and homeostasis. Abnormal ACE activity has been linked to various health conditions, including hypertension, heart failure, and diabetic complications. Researchers have increasingly focused on ACE recombinant proteins to better understand its structure and function, as well as to explore therapeutic interventions. The ability to produce ACE in a recombinant form allows for detailed studies of its enzymatic activity, substrate specificity, and potential inhibitors, which are critical for drug development. Furthermore, recombinant ACE proteins can be utilized in diagnostic assays and in the characterization of angiotensin peptides, enhancing our understanding of their physiological and pathophysiological roles. The emergence of biotechnological tools and techniques has propelled the advancement of ACE studies, facilitating the development of novel ACE-targeted therapies and improving our understanding of cardiovascular diseases on a molecular level. This research not only aims to optimize treatment strategies for existing cardiovascular disorders but also holds promise for innovative approaches to preventive medicine and personalized healthcare solutions.